申请人:Chemisch Pharmazeutische Forschungsgesellschaft
公开号:US04929616A1
公开(公告)日:1990-05-29
The invention relates to a novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxide of the formula ##STR1## in which R.sub.1 denotes hydrogen, (C.sub.1 -C.sub.4)-alkyl or halogen, R.sub.2 denotes halogen, and n denotes an integer from 2 to 6, the pharmaceutically acceptable acid-addition salt thereof, a process for their preparation, and their use in medicament for the treatment of anxiety states.
这项发明涉及一种新颖的基本取代的5-卤噻异噻唑-3(2H)-酮1,1-二氧化物,其化学式为##STR1##其中R.sub.1代表氢、(C.sub.1 -C.sub.4)-烷基或卤素,R.sub.2代表卤素,n代表一个从2到6的整数,其药学上可接受的酸加盐,其制备方法,以及它们在治疗焦虑状态的药物中的应用。